首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 4期 肝纤维化/肝硬化的可逆性及评价 => 专家论坛 =>中医对肝纤维化逆转的..
中医对肝纤维化逆转的认识与治疗
Advances in the understanding and treatment of liver fibrosis in traditional Chinese medicine
文章发布日期:2019年03月07日  来源:  作者:刘成海,赵志敏,吕靖  点击次数:229次  下载次数:98次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:肝纤维化见于多种慢性肝病。历史上,中医药基于辨证论治的临床实践形成了诊治肝纤维化的独特经验;近年来,通过实验探索与循证医学研究,产生了抗肝纤维化的中成药与有效经验方,并初步形成了中西医结合抗肝纤维化治疗方案。随着中药质量提高与临床研究发展,质量稳定、疗效显著的抗肝纤维化中药新药必将进一步问世,以满足慢性肝病患者的临床需求,并促进中医药的现代化与国际化发展。
【Abstract】:Liver fibrosis is commonly seen in various chronic liver diseases. In history, traditional Chinese medicine (TCM) clinical practice based on syndrome differentiation and treatment formed unique experience in the diagnosis and treatment of liver fibrosis; in recent years, studies based on experimental exploration and evidence-based medicine have formed effective Chinese patent drugs and experienced prescriptions for the treatment of liver fibrosis, as well as integrated traditional Chinese and Western medicine regimens. With the improvement in the quality of TCM drugs and the development of related clinical studies, new TCM drugs with stable quality and marked clinical effect will be launched for the treatment of liver fibrosis, so as to meet the clinical needs of patients with chronic liver diseases and promote the modern and international development of TCM.
【关键字】:肝硬化; 中草药; 中医疗法
【Key words】:liver cirrhosis; drugs, Chinese herbal; TCM therapy
【引证本文】:LIU CH, ZHAO ZM, LYU J. Advances in the understanding and treatment of liver fibrosis in traditional Chinese medicine[J]. J Clin Hepatol, 2019, 35(4): 728-733. (in Chinese)
刘成海, 赵志敏, 吕靖. 中医对肝纤维化逆转的认识与治疗[J]. 临床肝胆病杂志, 2019, 35(4): 728-733.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号